Introduction: The aim of the study was to investigate and identify the predictors associated with the incidence of seizures in patients with encephalocele (EC). Methods: A retrospective analysis was undertaken of patients treated for EC at a tertiary medical center in Tehran between 2010 and 2021. Data including age at presentation, gender, location, size, and content of EC, ventriculomegaly, hydrocephalus, associated anomalies, and neurodevelopmental delay (NDD) were evaluated for their prognostic value. In addition, univariate and multivariate analyses were performed to identify the correlation between independent predictors and seizure incidence. Results: One hundred and two cases of EC were identified. Seventy-one ECs (69.6%) were posterior ECs, while 31 (30.4%) were anterior. Neural tissue was found in 43 (42.2%) of the ECs. Thirty-three patients (32.4%) had ventriculomegaly, of which 90.9% underwent shunt placement for progressive or symptomatic hydrocephalus. Seizure was found in 26 (25.5%) patients. On univariate analysis, presence of other anomalies, postoperative infections, and NDD were associated with seizures (p < 0.05). When the anomalies were categorized into intracranial and extracranial groups in univariate analysis, none was associated with statistically significant increase in seizure (p values of 0.09 and 0.61, respectively). Although according to multivariate analysis, only the association between other associated anomalies and seizure was near significant (OR: 2.0, 95% CI: 0.95–4.2, p = 0.049). Children with NDD and postoperative infection were, respectively, 3.04 and 1.3 times more at risk to experience seizures compared to other patients. Conclusion: We found a rate of 25.5% risk of seizure in patients with EC. This study could not find any significant predictors of seizure in children with EC. However, pediatric patients with postoperative infections including sepsis, wound infection, and NDD require more consideration to reduce the risk of seizure.

Encephaloceles (ECs) are classified according to their location [1]. The prevalence of EC is estimated to be 0.8–4 in every 10,000 live births [2, 3]. Although rare, the association between ECs and seizure is well established in some patients with seizure syndrome including focal and generalized tonic-clonic seizures [4, 5]. These ECs are diagnosed only by neuroimaging including either computerized tomography (CT) scan or magnetic resonance imaging (MRI) to confirm a bony defect on the CT scan or differentiate the EC content in MRI [6, 7]. Although EC has been discovered in 0.3% of the MRI performed for newly diagnosed or unprovoked seizures [8], neuroimaging, particularly MRI T2-weighted sequence, has high sensitivity for all types of ECs, even the small ones associated with temporal lobe seizures [9‒11]. Additionally, Campbell et al. [12] observed that application of 3T MRI increased the detection rate of temporal ECs in patients with seizures.

ECs discovered during seizure investigations are mostly reported among the adult population [5, 6, 13–20]. However, there are notable cases in pediatric patients with a history of ECs and the occurrence of seizures [2, 21–27]. The main differences between seizure in adult and pediatric ECs lie not only in the onset of symptoms but also in the size of EC and other associated anomalies like hydrocephalus and intracranial/extracranial anomalies [21, 22, 28]. Most EC-related seizures in pediatric patients occur after resection of the EC [23‒25, 29]. Contrarily, ECs in adults – especially temporal ECs – are often diagnosed incidentally on imaging during investigations of intractable seizures [6, 9, 14, 16–19, 30]. Also, compared to adults, pediatric cases are often associated with larger EC size and other anomalies like hydrocephalus and neurodevelopmental delay (NDD) [2, 3, 31]. However, in terms of etiology, congenital factor seems to be common in all age groups [3, 14, 24, 30].

Literature has shown that ECs associated with seizure consisted mainly of case report and series of seizures associated with temporal ECs [5, 12, 13, 15–18, 21, 27]. Temporal ECs include anterobasal, lateral, or medial variants. Anterior and lateral temporal ECs can be associated with cerebrospinal fluid (CSF) otorrhea but rarely seizures [5, 8, 9, 14, 18, 23, 32]. Contrarily, medial temporal ECs commonly present with seizures/epilepsy that are often intractable to medications and mostly require surgical intervention [16, 17, 33–36]. Interestingly, ECs of several locations including the motor cortex [30], frontal [37], or occipital lobe [3, 22, 24, 29] have also been reported to cause seizures. However, besides the vast knowledge about surgical repair for temporal EC associated with intractable seizures [6, 11, 13, 15–17, 20, 21], little is known about the proper management of seizures in children with EC before and after EC resection. Also, till date, there has not been any study that sought to find predictors of seizure in pediatric patients with EC, even though seizures have been reported in large studies [2, 3, 24, 31]. Prediction of seizure development in children with ECs could provide a more realistic perspective for their caregivers and help physicians tailor their follow-up sessions. In this study, we reviewed our series of patients with EC and analyzed the predictors associated with seizure incidence. The management, follow-up, and overall outcome are presented.

All patients with EC who underwent operations in the pediatric neurosurgery department of Children’s Medical Center, Tehran, between the years 2010 and 2021 were enrolled in this study. The demographic information of 102 patients treated for ECs was retrospectively collected. Information about EC (location, size, neural tissue in the sac), ventriculomegaly/symptomatic hydrocephalus, associated anomalies, CSF shunting, seizure, meningitis, postoperative infection (sepsis, wound infections), neurodevelopmental status [3], and final status (alive or dead) was gathered. The diagnosis of seizures was made clinically when a child showed signs and symptoms of seizures. Ventriculomegaly was defined based on brain imaging. The diagnosis of hydrocephalus was also primarily based on imaging including ultrasound, brain CT scan, or MRI associated with clinical signs and symptoms of intracranial hypertension including unusual enlargement of head size, persistent vomiting, bulge and tens fontanel, or sunset eye.

The presence of neural tissue in the EC was confirmed by intraoperative findings, histopathological reports, or imaging reports. The EC sac was categorized into two parts: anterior and posterior. The anterior lesions included basal (sphenoorbital, sphenomaxillary, and trans-sphenoidal) and sincipital (nasofrontal, nasoethmoidal, nasoorbital), while the posterior lesions included temporal, parietal, occipitocervical, and occipital ECs. After surgery, all patients were followed up in the outpatient clinic. During clinical visits, all patients were examined for signs of hydrocephalus (abnormal increase of head circumference, sunset eye, bulge, or tense fontanel) and neurodevelopmental status. Also, a pediatric neurologist examined patients with a history of seizures and managed them with regular clinical visits, electroencephalography, and antiepileptic medications. Follow-up data were documented in patients’ medical files. Besides the collection of data from the medical records of patients, patients were also interviewed for additional data about seizures and the NDD status of the children (according to the Center for Disease Control and Prevention/CDC developmental milestone scores [3]) through interviews in the clinic or phone calls to their parents.

Statistical Analyses

Statistical analyses were performed using SPSS statistical software (version 25.0 for Windows, IBM Corp.). Continuous variables were presented as median ± standard deviation, and dichotomous variables were expressed as percentages. Categorical variables were defined as frequency, constituent ratio, and crosstab. Cross-tabulation analyses and univariate analyses of various predictors of seizure incidence were accomplished.

Variables of statistically significant associations with seizures were included in multivariate logistic regression. The exact logistic regression was used to estimate and test the association between independent variables and seizures. The means of continuous variables were compared between seizure and non-seizure groups using independent sample T test. All statistical tests were 2 sided, and data were deemed to be statistically significant when p < 0.05.

Demographic and Clinical Characteristics

Among 102 patients involved in this study, 52 were male. Patients aged from 1 day to 7.5 years at the time of surgery had a median age of 4 months. Seventy-one patients (69.6%) had posterior ECs, while 31 (30.4%) had anterior ECs. Seven children were born preterm (6.9%) (Table 1).

Table 1.

Demographic and clinical characteristics of patients

VariablesValue
Age in months (median [IQR]) 4 (0.3–90) 
Sex, n (%) 
 Male 52 (51) 
 Female 50 (49) 
Age at surgery, n (%) 
 <2 months 22 (21.6) 
 2–6 months 34 (33.3) 
 7–12 months 20 (19.6) 
 13–36 months 16 (15.7) 
 More than 36 months 10 (9.8) 
Term delivery, n (%) 
 Preterm 7 (6.9) 
 Term 95 (93.2) 
Sac location, n (%) 
 Anterior 31 (30.4) 
  Nasoorbital 5 (16.1) 
  Nasoethmoidal 6 (19.4) 
  Nasofrontal 10 (32.3) 
  Trans-sphenoidal 6 (19.4) 
 Basal 4 (12.9) 
 Posterior 71 (69.6) 
  Occipital 60 (84.5) 
  Parietal 6 (8.5) 
  Parieto-occipital 4 (5.6) 
  Temporal 1 (1.4) 
Size of EC sac, n (%) 
 <5 cm 82 (80.4) 
 5–10 cm 14 (13.7) 
 ≥10 cm 6 (5.9) 
Presence of neural tissue, n (%) 
 No 31 (30.4) 
 Yes 43 (42.2) 
 Missing data 28 (27.5) 
Ventriculomegaly, n (%) 33 (32.4) 
CSF leakage, n (%) 19 (18.6) 
Meningitis, n (%) 6 (5.9) 
Other infections,* n (%) 25 (24.5) 
Seizures, n (%) 26 (25.5) 
Other anomalies N = 39 
 Intracranial anomalies 23 
  Corpus callosum agenesis 
  Dandy walker syndrome 
  Microcephaly 
  Colpocephaly 
  Chiari malformation 
  Arachnoid cyst 
  Iniencephaly 
  Cerebella agenesis 
  Dolicocephaly 
  Holoprosencephaly 
  Mega cisterna magna 
  Cutis aplasia 
 Extracranial anomalies 22 
  Cleft palate 
  Face and nose deformities 
  Cervical vertebral defects 
  Hypertelorism 
  Limb deformities (polydactyly, syndactyly) 
  Congenital heart defects 
  Choanal atresia 
  Crossed ectopic kidney 
  Klippel-feil syndrome 
  Spinal dysraphism 
  Congenital absence of radius 
VariablesValue
Age in months (median [IQR]) 4 (0.3–90) 
Sex, n (%) 
 Male 52 (51) 
 Female 50 (49) 
Age at surgery, n (%) 
 <2 months 22 (21.6) 
 2–6 months 34 (33.3) 
 7–12 months 20 (19.6) 
 13–36 months 16 (15.7) 
 More than 36 months 10 (9.8) 
Term delivery, n (%) 
 Preterm 7 (6.9) 
 Term 95 (93.2) 
Sac location, n (%) 
 Anterior 31 (30.4) 
  Nasoorbital 5 (16.1) 
  Nasoethmoidal 6 (19.4) 
  Nasofrontal 10 (32.3) 
  Trans-sphenoidal 6 (19.4) 
 Basal 4 (12.9) 
 Posterior 71 (69.6) 
  Occipital 60 (84.5) 
  Parietal 6 (8.5) 
  Parieto-occipital 4 (5.6) 
  Temporal 1 (1.4) 
Size of EC sac, n (%) 
 <5 cm 82 (80.4) 
 5–10 cm 14 (13.7) 
 ≥10 cm 6 (5.9) 
Presence of neural tissue, n (%) 
 No 31 (30.4) 
 Yes 43 (42.2) 
 Missing data 28 (27.5) 
Ventriculomegaly, n (%) 33 (32.4) 
CSF leakage, n (%) 19 (18.6) 
Meningitis, n (%) 6 (5.9) 
Other infections,* n (%) 25 (24.5) 
Seizures, n (%) 26 (25.5) 
Other anomalies N = 39 
 Intracranial anomalies 23 
  Corpus callosum agenesis 
  Dandy walker syndrome 
  Microcephaly 
  Colpocephaly 
  Chiari malformation 
  Arachnoid cyst 
  Iniencephaly 
  Cerebella agenesis 
  Dolicocephaly 
  Holoprosencephaly 
  Mega cisterna magna 
  Cutis aplasia 
 Extracranial anomalies 22 
  Cleft palate 
  Face and nose deformities 
  Cervical vertebral defects 
  Hypertelorism 
  Limb deformities (polydactyly, syndactyly) 
  Congenital heart defects 
  Choanal atresia 
  Crossed ectopic kidney 
  Klippel-feil syndrome 
  Spinal dysraphism 
  Congenital absence of radius 

IQR, interquartile range; EC, encephalocele; CSF, cerebrospinal fluid.

*Other infection included sepsis and wound infections.

The EC size ranged from 0.5 to 15 cm, with a median size of 3 cm (IQR: 2–5). Neural tissue was inside the sac in 43 (42.2%) of the ECs. Forty-five patients (44.1%) had associated intracranial and extracranial anomalies. Majority of surgical interventions were performed at ages less than 6 months (54.6%). Thirty-three patients (32.4%) had ventriculomegaly, of which 90.9% underwent shunt placement for progressive ventriculomegaly/symptomatic hydrocephalus. Leakage of CSF was observed in 19 (18.6%) cases. However, meningitis occurred in only 6 (5.9%) patients. Other infections including sepsis and wound infection also occurred in 25 (24.5%) cases (Table 1).

Demographic and Seizure Outcomes

Twenty-six (25.5%) patients had seizures, which occurred before surgery in 2 and after EC resection/postoperative in 24 patients. Male children (61.5%) had more seizure episodes than females (38.5%). Sixteen (61.5%) of the seizure cases had posterior ECs, while 10 (38.5%) were associated with anterior ECs. Majority of seizures were observed between 2 and 6 months of age (26.9%) and between 6 and 12 months (26.9%), respectively. History of prematurity was found in 2 (7.7%) of 26 patients with seizures. Presence of prematurity did not have a statistically significant association with seizure occurrence (p = 0.22). Interestingly, most seizures occurred in the patients with ECs size below 5 cm. The difference between the presence and absence of other anomalies was marginal in terms of seizure development (p = 0.01). Categorizing the anomalies into extracranial and intracranial anomalies, a p value of 0.61 for extracranial and 0.09 for intracranial anomalies was calculated that was not statistically significant. For postoperative seizure, 15 (57.7%) patients had seizures after EC repair, 9 (34.6%) had seizures after ventriculoperitoneal shunting for progressive ventriculomegaly with symptomatic hydrocephalus, and 2 (7.7%) seizures occurred after an endoscopic procedure for anterior ECs. Among 6 (5.9%) patients with meningitis, 3 had seizures. However, 12 of the 25 patients with postoperative infection had seizures (Table 2).

Table 2.

Analysis of different risk factors and seizure outcomes

VariablesSeizures (%)p value*
yes (n = 26)no (n = 76)
Age at surgery, months   0.165 
 <2 m 4 (15.4) 18 (23.7) 
 2–6 m 7 (26.9) 27 (35.5) 
 7–12 m 7 (26.9) 13 (17.1) 
 13–36 m 4 (15.4) 12 (15.8) 
 >36 m 4 (15.4) 6 (7.9) 
Time of delivery   0.662 
 Preterm 2 (7.7) 5 (6.6) 
 Term 24 (92.3) 71 (93.4) 
Gender   0.154 
 Males 16 (61.5) 36 (47.4) 
 Female 10 (38.5) 40 (52.6) 
Size of EC sac   0.284 
 <5 cm 23 (88.5) 59 (77.6) 
 >5 cm 3 (11.5) 17 (22.4) 
Location of sac   0.213 
 Anterior 10 (38.5) 21 (27.6) 
 Posterior 16 (61.5) 55 (72.4) 
Other associated anomalies (n = 39)   0.01 
 Yes 14 (53.8) 25 (32.9) 
 No 12 (46.2) 51 (67.1) 
Presence of neural tissue inside EC   0.067 
 Yes 14 (53.8) 29 (38.2) 
 No 5 (19.2) 26 (34.2) 
 Missing data 7 (26.9) 21 (27.6) 
Ventriculomegaly   0.126 
 Yes 11 (42.3) 21 (27.6) 
 No 15 (57.7) 55 (72.4) 
EC intervention   0.357 
 EC resection only 15 (57.7) 59 (77.6) 
 VPS post EC resection 9 (34.6) 16 (21.1) 
 Endoscopic resection 2 (7.7) 1 (1.3) 
Meningitis   0.171 
 Yes 3 (11.5) 3 (3.9) 
 No 23 (88.5) 73 (96.1) 
Post-op infectionsa   0.004 
 Yes 12 (46.2) 13 (17.1) 
 No 14 (53.8) 63 (82.9) 
CSF leak   0.446 
 Yes 5 (19.2) 12 (15.8) 
 No 21 (80.8) 64 (84.2) 
NDD outcomes   0.011 
 Normal 14 (53.4) 49 (64.5) 
 Mild to moderate 4 (15.4) 10 (13.2) 
 Severe 8 (30.8) 9 (11.8) 
 Missing data 0 (0) 8 (10.5) 
VariablesSeizures (%)p value*
yes (n = 26)no (n = 76)
Age at surgery, months   0.165 
 <2 m 4 (15.4) 18 (23.7) 
 2–6 m 7 (26.9) 27 (35.5) 
 7–12 m 7 (26.9) 13 (17.1) 
 13–36 m 4 (15.4) 12 (15.8) 
 >36 m 4 (15.4) 6 (7.9) 
Time of delivery   0.662 
 Preterm 2 (7.7) 5 (6.6) 
 Term 24 (92.3) 71 (93.4) 
Gender   0.154 
 Males 16 (61.5) 36 (47.4) 
 Female 10 (38.5) 40 (52.6) 
Size of EC sac   0.284 
 <5 cm 23 (88.5) 59 (77.6) 
 >5 cm 3 (11.5) 17 (22.4) 
Location of sac   0.213 
 Anterior 10 (38.5) 21 (27.6) 
 Posterior 16 (61.5) 55 (72.4) 
Other associated anomalies (n = 39)   0.01 
 Yes 14 (53.8) 25 (32.9) 
 No 12 (46.2) 51 (67.1) 
Presence of neural tissue inside EC   0.067 
 Yes 14 (53.8) 29 (38.2) 
 No 5 (19.2) 26 (34.2) 
 Missing data 7 (26.9) 21 (27.6) 
Ventriculomegaly   0.126 
 Yes 11 (42.3) 21 (27.6) 
 No 15 (57.7) 55 (72.4) 
EC intervention   0.357 
 EC resection only 15 (57.7) 59 (77.6) 
 VPS post EC resection 9 (34.6) 16 (21.1) 
 Endoscopic resection 2 (7.7) 1 (1.3) 
Meningitis   0.171 
 Yes 3 (11.5) 3 (3.9) 
 No 23 (88.5) 73 (96.1) 
Post-op infectionsa   0.004 
 Yes 12 (46.2) 13 (17.1) 
 No 14 (53.8) 63 (82.9) 
CSF leak   0.446 
 Yes 5 (19.2) 12 (15.8) 
 No 21 (80.8) 64 (84.2) 
NDD outcomes   0.011 
 Normal 14 (53.4) 49 (64.5) 
 Mild to moderate 4 (15.4) 10 (13.2) 
 Severe 8 (30.8) 9 (11.8) 
 Missing data 0 (0) 8 (10.5) 

EC, encephalocele; CSF, cerebrospinal fluid; m, months; NDD, neurodevelopmental delay.

*p values <0.05 are significant.

aPost-op infections included mainly of sepsis and wound infections.

Neurodevelopmental status was evaluated with CDC milestones in 94 patients, which revealed 17 patients (18.1%) had severe NDD, 14 (14.9%) had mild/moderate delay, and 63 (67%) had a normal neurodevelopmental outcome. Eight (30.8%) of 17 patients with severe NDD had seizures, while 4 (15.4%) of 14 with mild to moderate NDD found seizures, and 14 (53.4%) of 63 with normal neurodevelopment had seizures. This difference was statistically significant (p = 0.011). The median follow-up according to the last clinical visit was 9 months, while the median follow-up by phone calls was 96 months. At the last follow-up visit, seizures in 19 (70.4%) children were controlled (Engel class 1 and 2) with antiepileptic medication, and 1 (3.7%) patient was dead. Seven (25.9%) patients had lost to follow up in terms of seizure control. The overall survival rate of 102 ECs was 87.3%. Five (4.9%) patients in the total population were dead during follow-up, while 8 (7.8%) patients were lost to follow up (Table 3).

Table 3.

Follow-up outcomes according to duration, management of hydrocephalus, seizure, and overall survival

VariablesValues
Follow-up duration (median) 
 Last clinical visit 9 months 
 Phone interview 96 months 
Hydrocephalus management, n (%) 
 Shunt placement 30 (90.9) 
Seizure controlled, n (%) 
 Yes 19 (70.4) 
 Died 1 (3.7) 
 Missing data/lost to follow-up 7 (25.9) 
Overall survival rate, n (%) 
 Alive 89 (87.3) 
 Died 5 (4.9) 
 Lost to follow-up 13 (12.7) 
VariablesValues
Follow-up duration (median) 
 Last clinical visit 9 months 
 Phone interview 96 months 
Hydrocephalus management, n (%) 
 Shunt placement 30 (90.9) 
Seizure controlled, n (%) 
 Yes 19 (70.4) 
 Died 1 (3.7) 
 Missing data/lost to follow-up 7 (25.9) 
Overall survival rate, n (%) 
 Alive 89 (87.3) 
 Died 5 (4.9) 
 Lost to follow-up 13 (12.7) 

Cross-Tabulation Analyses of Various Predictors of Seizure Outcomes

Table 2 illustrates the cross-tabulation analyses between predictors and seizure incidence. The results of univariate analysis showed no correlation between age at surgery (p = 0.165), gender (p = 0.154), time of delivery (p = 0.662), EC location (p = 0.213), size of EC sac (p = 0.284), ventriculomegaly (p = 0.126), meningitis (p = 0.171), CSF leak (p = 0.446), type of surgery (p = 0.357), and seizure development. However, according to univariate analysis, there was a strong correlation between postoperative infection and seizures (p = 0.004). Of 27 patients who developed seizures, 14 (53.8%) had neural tissue inside the sac, while 5 (19.2%) did not. χ2 test showed a marginal correlation between presence of neural tissue in the sac and seizure (p = 0.067). Although only 14 of 39 patients with other anomalies had seizures, this correlation was statistically significant (p = 0.01). Additionally, NDD correlated with seizure development (p = 0.011).

Logistic Regression Analysis of Predictors with Seizures

Considering seizure as a dependent outcome, all variables were reanalyzed using the univariate and multivariate models. The analyses were adjusted for age at surgery, gender, term delivery, posterior location, EC sac size, NDD, ventriculomegaly, associated anomalies, meningitis, postoperative infections, and CSF leak. Results of the univariate model indicate that the presence of other anomalies, postoperative infection, and NDD were associated with an increased risk of seizure. Again, the three variables were inputted into a multivariate model. The multivariate model showed that only the presence of other anomalies was statistically near significant associated with seizure (OR: 2.0, 95% CI: 0.95–4.2, p = 0.049). Categorizing the associated anomalies into intracranial and extracranial was performed to evaluate their importance for seizure occurrence in a multivariate model. Neither extracranial nor intracranial anomalies in patients with EC had a statistically significant association with an increased risk of seizure (p = 0.61 and p = 0.09, respectively). Although not statistically significant, children with postoperative infection were 3.04 times more likely to have seizures (95% CI: 1.07–8.58; p = 0.17), while children with NDD were 1.3 times (95% CI: 0.9–4.2; p = 0.49) more likely to develop seizures (Table 4).

Table 4.

Comparison of seizure predictors in patients with EC according to univariate and multivariate analysis

VariableSeizuresUV OR (95% CI)*MV OR (95% CI)*
yes (26), n (%)no (76), n (%)
Age at surgery  1.00 (0.98–1.03, p = 0.79)  
Gender  1.00 (0.98–1.03, p = 0.15)  
 Male 16 (61.5) 36 (47.4)   
 Female 10 (38.5) 39 (52.6)   
Term delivery 24 (92.3) 71 (93.4) 1.4 (0.2–8.3, p = 0.31)  
Posterior location 16 (61.5) 55 (72.4) 0.6 (0.2–1.5, p = 0.93)  
Sac size >5 cm 3 (11.5) 17 (22.4) 0.9 (0.7–1.07, p = 0.17)  
Neural tissue presence 14 (53.8) 29 (38.2) 2.5 (0.7–7.9, p = 0.27)  
NDD 12 (46.2) 19 (25.0) 1.4 (1.004–2.0, p = 0.03) 1.3 (0.9–4.2, p = 0.46) 
Ventriculomegaly 11 (42.3) 21 (27.6) 1.8 (0.7–4.5, p = 0.36)  
Other anomalies 14 (53.8) 25 (32.9) 2.3 (1.1–4.8, p = 0.01) 2.0 (0.95–4.2, p = 0.049) 
 Intracranial anomalies p = 0.09 
 Extracranial anomalies p = 0.61 
Meningitis 3 (11.5) 3 (3.9) 3.1 (0.59–16.8, p = 0.45)  
Post-op infection 12 (46.2) 13 (17.1) 4.15 (1.5–11.0, p = 0.01) 3.04 (1.07–8.58, p = 0.16) 
 Post-op CSF leak 5 (19.2) 12 (15.8) 1.4 (0.1–17.0, p = 0.71)  
VariableSeizuresUV OR (95% CI)*MV OR (95% CI)*
yes (26), n (%)no (76), n (%)
Age at surgery  1.00 (0.98–1.03, p = 0.79)  
Gender  1.00 (0.98–1.03, p = 0.15)  
 Male 16 (61.5) 36 (47.4)   
 Female 10 (38.5) 39 (52.6)   
Term delivery 24 (92.3) 71 (93.4) 1.4 (0.2–8.3, p = 0.31)  
Posterior location 16 (61.5) 55 (72.4) 0.6 (0.2–1.5, p = 0.93)  
Sac size >5 cm 3 (11.5) 17 (22.4) 0.9 (0.7–1.07, p = 0.17)  
Neural tissue presence 14 (53.8) 29 (38.2) 2.5 (0.7–7.9, p = 0.27)  
NDD 12 (46.2) 19 (25.0) 1.4 (1.004–2.0, p = 0.03) 1.3 (0.9–4.2, p = 0.46) 
Ventriculomegaly 11 (42.3) 21 (27.6) 1.8 (0.7–4.5, p = 0.36)  
Other anomalies 14 (53.8) 25 (32.9) 2.3 (1.1–4.8, p = 0.01) 2.0 (0.95–4.2, p = 0.049) 
 Intracranial anomalies p = 0.09 
 Extracranial anomalies p = 0.61 
Meningitis 3 (11.5) 3 (3.9) 3.1 (0.59–16.8, p = 0.45)  
Post-op infection 12 (46.2) 13 (17.1) 4.15 (1.5–11.0, p = 0.01) 3.04 (1.07–8.58, p = 0.16) 
 Post-op CSF leak 5 (19.2) 12 (15.8) 1.4 (0.1–17.0, p = 0.71)  

UV, univariate; MV, multivariate.

*p values <0.05 are significant.

There are previous series that have documented seizures in children with ECs [2, 3, 31, 38, 39]. However, this is the first retrospective large series that has sought to investigate risk factors for seizures in patients with ECs. According to univariate analysis, our results showed that postoperative infections, the presence of neural tissue inside the ECs, other associated anomalies, and NDD were significant or marginally significant predictors of seizure development. However, in a multivariate model, none of them was a significant predictor of seizure occurrence.

Prevalence and Pathophysiology of Seizures Associated with EC

The estimated prevalence of seizures in the present study was 25.5%. This rate was higher than previous studies [2, 23–26, 29, 31, 38–40]. For instance, Lo et al. [2], Da Silva et al. [31], Bui et al. [38], Leelanukrom et al. [40], Nagy and Saleh [24], Mahajan et al. [25], Mahapatra and Agrawal [23], Rehman et al. [29], and Kabre et al. [26] estimated the prevalence of seizures to be 20%, 13%, 13.6%, 4.9%, 11.8%, 1.7%, 3.9%, 15%, and 14%, respectively. Although seizures can be a preoperative symptom in children [22, 41–44], majority of these symptoms occur as a postoperative complication [23, 24, 26, 40] and may be correlated with serious postoperative infections like sepsis and meningitis [23, 39, 40]. In our study, 24 instances of seizures occurred postoperatively after EC resection or shunt placement subsequent to EC resection. Concordant with some authors [23, 39, 40], we found a strong correlation between postoperative infections and seizures (p = 0.004). However, further analysis showed no association between meningitis, CSF leak, and seizure development.

Other evidence suggests that hydrocephalus and its management could also provoke seizures. Almost half (42.3%) of the patients with seizures in this series had progressive ventriculomegaly/symptomatic hydrocephalus or underwent shunting for hydrocephalus treatment. Particularly, our data showed that 9 patients had tonic-clonic seizures after shunt placement for progressive hydrocephalus. Additionally, Leelanukrom et al. [40] reported three EC cases in which hydrocephalus resulted in tonic-clonic seizures. However, we found no correlation between ventriculomegaly/hydrocephalus and seizure occurrence (p = 0.126). Contrarily, Da Silva et al. [31] and Lo et al. [2] in a univariate analysis showed strong correlations between hydrocephalus and seizures (p = 0.001). Seeburg et al. [39] reported two cases in which one premature hydrocephaly infant developed seizures 1 month after shunting. Bui et al. [38] argued that the presence of hydrocephalus and seizures/epilepsy can independently and significantly lower the overall prognosis of children with ECs. However, the constellation of associated brain anomalies in ECs, progressive hydrocephalus, resection of dysplastic brain inside the sac, shunting procedure, and infection can explain the pathophysiology of postoperative seizures. Notwithstanding, further studies are needed to provide concrete evidence to support this explanation.

Anomalies, Seizures, and NDD

As mentioned earlier, seizures may also occur as a presenting or preoperative symptom. In this cohort, only two seizures were found preoperatively. The first child was a term female infant who began having seizures a few weeks after birth. Subsequent evaluation showed progressive hydrocephalus with Dandy Walker malformations associated with an occipital EC. EC resection was performed, and VPS was inserted for hydrocephalus. Although her seizure was under control, a 72-month follow-up showed severe NDD. The second child was a male microcephaly neonate who had a huge occipital EC of 10.5 cm at birth. Neuroimaging confirmed neural tissue inside the sac, Chiari malformation, and corpus callosum agenesis. On the third day of birth, the patient developed a seizure and surgical team decided to perform shunting before EC resection. Again, 120 months of follow-up revealed severe NDD in this patient.

Our univariate analyses confirm a correlation between the presence of other anomalies, presence of neural tissue in the sac, postoperative infections, and NDD with seizure occurrence. However, on the multivariate model, only the association between the presence of other anomalies and seizures was statistically near significant (p = 0.049). Subcategorizing the associated anomalies as intracranial and extracranial showed no statistically significant association with seizure. We observed that children with NDD were 1.3 times more likely to have recurrent seizures even with antiepileptic medication. In turn, seizures can further deteriorate NDD outcomes and negatively impact the overall health of the affected child [38]. Consistent with our finding, Lo et al. [2] showed that patients with seizures had a 4.09 more risk of developing NDD. Rehman et al. [29] also reported a patient with NDD who developed a seizure. According to them, although the seizure was well controlled, the patient’s developmental milestones showed no improvement [29]. Contrarily to the above findings, Da Silva et al. [31] found no association between seizures and NDD (p = 0.12). However, there are several studies that have reported patients with ECs and associated anomalies who developed seizures and NDD [22, 41, 44].

Association between Other Predictors and Seizures

The mean EC size in seizure (N = 26) and non-seizure patients (N = 76) in our study was 3.4 ± 2.5 and 4.1 ± 3.3, respectively. This difference was not statistically significant according to the independent sample T test (p = 0.286). Pettersson et al. [10] in their series characterized MRI features of middle cranial fossa ECs in seizure and non-seizure patients. Similar to our findings, they observed that the EC size and degree of parenchymal morphologic distortion may not be useful in predicting the likelihood of seizure occurrence [10]. Our present results show a higher prevalence of seizure incidence in male children. However, this was not statistically significant (p = 0.154). Temporal EC is known to cause seizures [12, 13, 15–18, 21, 27]. Also, 61.5% of patients with posterior lesions (with only 1 case of temporal EC) in this cohort had seizures. However, EC sac location did not significantly correlate with the occurrence of seizures in the affected patients. Our data also showed no correlation between time of delivery, age at surgery, and seizure development. Particularly, the mean age at surgery between patients with seizures (N = 26; mean age at surgery of 12.8 ± 14.7 months) and those without seizures (N = 76; mean age at surgery of 10.2 ± 16.6) were not different (p = 0.484). Moreover, we have shown that the type of surgery (open or endoscopic surgery) does not predispose the patients to develop seizures.

Management, Follow-Up, and Prognosis of Seizures

In this study, seizures were managed mainly with antiepileptic medication. Seizure control was achieved in 70.4% of cases, with only 1 patient died from seizure related complications upon follow-up. Apart from Mahapatra and Agrawal who documented intractable recurrent seizures in four children in their series in spite of antiepileptic medication [23], the overall prognosis of seizures in patients with EC is favorable [24, 29]. Because postoperative seizures can develop in patient with no preoperative seizures some authors suggested administration of antiepileptic medications before surgery [40]. Additionally, proper and adequate treatment of postoperative infections is mandated since this complication could trigger seizures development. The overall survival rate of children with EC has been shown to be high [2, 24, 31]. However, adequate management for worse outcomes like seizures and hydrocephalus are needed to reduce NDD and improve the survival.

Limitation

The main limitation of this study was missing data. For instance, although 102 patients were included in this study, data of histopathological diagnosis of the presence or absence of neural tissue were available in 74 cases only. We attribute the incomplete patients’ data to the retrospective design of the study. We admit that the final follow-up clinical evaluation through phone interviews was limited as the parents’ responses might be overestimated or underestimated according to their expectations, social background, or level of education. In spite of these limitations, we believe the findings of this retrospective study will be relevant to the literature and provide pertinent information for the neurosurgical management of patients with ECs.

This is the first large retrospective cohort that has evaluated seizure outcomes and investigated the effective factors. Univariate analysis showed a statistically significant correlation between postoperative infections, associated anomalies, the presence of neural tissue in the EC sac, NDD, and seizure incidence. However, in the multivariate model and dividing the anomalies into intracranial and extracranial groups, none of them found significant association with seizures. Children with postoperative infections had a 3.04 times higher risk of seizure, while those who had NDD had a 1.3 times higher risk of developing seizures.

This study was approved by the Institutional Ethics Committee of the Iran University of Medical Sciences (ethics code: IR.IUMS.FMD.REC.1401.460). The study is a retrospective study, in which data were drawn from the medical records of encephalocele patients admitted to our hospital. In their medical record, we have taken a medical consent from their parents that their data (with respect to their privacy and confidentiality) is used for research. If it is needed, we can send you copy of the informed consent form signed by parents in Farsi language to the journal.

The authors have no conflicts of interest to declare.

No funding sources were used.

Amirhosein Nejat: acquisition of data, analysis and interpretation of data, drafting the article, and revising with final approval. Samuel Berchi Kankam: acquisition of data, analysis and interpretation of data, drafting the article, and final approval. Vahid Heidari, Keyvan Tayebi Meybodi, and Sajedeh Karami: interpretation of data, drafting the article, and revising with final approval Zohreh Habibi: conception and design, analysis and interpretation of data, drafting the article, revising, and final approval. Farideh Nejat: conception and design, acquisition of data, analysis and interpretation of data, drafting the article, revising, and final approval.

All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.

1.
Wind JJ, Caputy AJ, Roberti F. Spontaneous encephaloceles of the temporal lobe. Neurosurg Focus. 2008;25(6):E11.
2.
Lo BW, Kulkarni AV, Rutka JT, Jea A, Drake JM, Lamberti-Pasculli M, et al. Clinical predictors of developmental outcome in patients with cephaloceles. J Neurosurg Pediatr. 2008;2(4):254–7.
3.
Kankam SB, Tavallaii A, Mohammadi E, Nejat A, Habibi Z, Nejat F. The neurodevelopmental outcomes of children with encephalocele: a series of 102 patients. J Neurosurg Pediatr. 2023;31(2):151–8.
4.
Morone PJ, Sweeney AD, Carlson ML, Neimat JS, Weaver KD, Abou-Khalil BW, et al. Temporal lobe encephaloceles: a potentially curable cause of seizures. Otol Neurotol. 2015;36(8):1439–42.
5.
Paule E, Freiman TM, Strzelczyk A, Reif PS, Willems LM, Wagner M, et al. Characteristics of bilateral versus unilateral temporal encephalocele-associated epilepsy. Seizure. 2019;71:13–9.
6.
Faulkner HJ, Sandeman DR, Love S, Likeman MJ, Nunez DA, Lhatoo SD. Epilepsy surgery for refractory epilepsy due to encephalocele: a case report and review of the literature. Epileptic Disord. 2010;12(2):160–6.
7.
Kıymaz N, Yılmaz N, Demir I, Keskin S. Prognostic factors in patients with occipital encephalocele. Pediatr Neurosurg. 2010;46(1):6–11.
8.
Saavalainen T, Jutila L, Mervaala E, Kälviäinen R, Vanninen R, Immonen A. Temporal anteroinferior encephalocele: an underrecognized etiology of temporal lobe epilepsy?Neurology. 2015;85(17):1467–74.
9.
Tse GT, Frydman AS, O’Shea M, Fitt GJ, Weintrob DL, Murphy MA, et al. Anterior temporal encephaloceles: elusive, important, and rewarding to treat. Epilepsia. 2020;61(12):2675–84.
10.
Pettersson DR, Hagen KS, Sathe NC, Clark BD, Spencer DC. MR imaging features of middle cranial fossa encephaloceles and their associations with epilepsy. AJNR Am J Neuroradiol. 2020;41(11):2068–74.
11.
Gasparini S, Ferlazzo E, Villani F, Didato G, Deleo F, Bellavia MA, et al. Refractory epilepsy and encephalocele: lesionectomy or tailored surgery?Seizure. 2014;23(7):583–4.
12.
Campbell ZM, Hyer JM, Lauzon S, Bonilha L, Spampinato MV, Yazdani M. Detection and characteristics of temporal encephaloceles in patients with refractory epilepsy. AJNR Am J Neuroradiol. 2018;39(8):1468–72.
13.
Ramos-Fresnedo A, Domingo RA, McGeary RC, Sirven JI, Feyissa AM, Tatum W, et al. Encephalocele-associated drug-resistant epilepsy of adult onset: diagnosis, management, and outcomes. World Neurosurg. 2021;151:91–101.
14.
Leblanc R, Tampieri D, Robitaille Y, Olivier A, Andermann F, Sherwin A. Developmental anterobasal temporal encephalocele and temporal lobe epilepsy. J Neurosurg. 1991;74(6):933–9.
15.
Mukae N, Kuga D, Murakami D, Komune N, Miyamoto Y, Shimogawa T, et al. Endonasal endoscopic surgery for temporal lobe epilepsy associated with sphenoidal encephalocele. Surg Neurol Int. 2021;12:379.
16.
Panov F, Li Y, Chang EF, Knowlton R, Cornes SB. Epilepsy with temporal encephalocele: characteristics of electrocorticography and surgical outcome. Epilepsia. 2016;57(2):e33–8.
17.
Mikula AL, ReFaey K, Grewal SS, Britton JW, Van Gompel JJ. Medial temporal encephalocele and medically intractable epilepsy: a tailored inferior temporal lobectomy and case report. Oper Neurosurg. 2020;18(1):E19–22.
18.
Hammer A, Baer I, Geletneky K, Steiner HH. Cerebrospinal fluid rhinorrhea and seizure caused by temporo-sphenoidal encephalocele. J Korean Neurosurg Soc. 2015;57(4):298–302.
19.
Yadav T, Shaikh M, Panda S, Khera P. Temporal encephalocele into transverse sinus in an adult with partial seizures: MRI evaluation of a rare site of brain herniation. Indian J Radiol Imaging. 2020;30(4):517–20.
20.
Sandhu MRS, Mandel M, McGrath H, Lamsam L, Farooque P, Bronen RA, et al. Management of patients with medically intractable epilepsy and anterior temporal lobe encephaloceles. J Neurosurg. 2022;136(3):709–16.
21.
Whiting DM, Awad IA, Miles J, Chou SS, Lüders H. Intractable complex partial seizures associated with occult temporal lobe encephalocele and meningoangiomatosis: a case report. Surg Neurol. 1990;34(5):318–22.
22.
Venkateshappa BM, Raju B, Rallo MS, Jumah F, Suresh SC, Gupta G, et al. Knobloch syndrome, a rare cause of occipital encephalocele and seizures: a case report. Pediatr Neurosurg. 2021;56(3):274–8.
23.
Mahapatra A, Agrawal D. Anterior encephaloceles: a series of 103 cases over 32 years. J Clin Neurosci. 2006;13(5):536–9.
24.
Nagy MR, Saleh AE. Hydrocephalus associated with occipital encephalocele: surgical management and clinical outcome. Egypt J Neurosurg. 2021;36(1):6–7.
25.
Mahajan C, Rath GP, Dash HH, Bithal PK. Perioperative management of children with encephalocele: an institutional experience. J Neurosurg Anesthesiol. 2011;23(4):352–6.
26.
Kabré A, Zabsonre DS, Sanou A, Bako Y. The cephaloceles: a clinical, epidemiological and therapeutic study of 50 cases. Neurochirurgie. 2015;61(4):250–4.
27.
Jagtap SA, Kurwale N, Patil S, Joshi A, Nilegaonkar S. Gyratory seizures as a presentation of temporal encephalocele. Epilepsia Open. 2019;4(2):355–8.
28.
de Souza JPSAS, Mullin J, Wathen C, Bulacio J, Chauvel P, Jehi L, et al. The usefulness of stereo-electroencephalography (SEEG) in the surgical management of focal epilepsy associated with “hidden” temporal pole encephalocele: a case report and literature review. Neurosurg Rev. 2018;41(1):347–54.
29.
Rehman L, Farooq G, Bukhari I. Neurosurgical interventions for occipital encephalocele. Asian J Neurosurg. 2018;13(2):233–7.
30.
Fountas KN, Smith JR, Jenkins PD, Murro AM. Spontaneous motor cortex encephalocele presenting with simple partial seizures and progressive hemiparesis: case report and review of the literature. Neurosurg Focus. 2005;19(3):E10.
31.
Da Silva SL, Jeelani Y, Dang H, Krieger MD, McComb JG. Risk factors for hydrocephalus and neurological deficit in children born with an encephalocele. J Neurosurg Pediatr. 2015;15(4):392–8.
32.
Fong MW, Sala‐Padro J, Bartley M, Dexter MA, Bleasel AF, Wong CH. The varied semiology of seizures in the context of small anterior temporal encephaloceles. Epileptic Disord. 2019;21(4):347–52.
33.
Giulioni M, Licchetta L, Bisulli F, Rubboli G, Mostacci B, Marucci G, et al. Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis. Seizure. 2014;23(2):164–6.
34.
Wichova H, Shew M, Alvi S, Lin J. A case of mesial temporal lobe sclerosis following temporal bone encephalocele repair for medically refractory seizures. Cureus. 2018;10(11):e3623.
35.
Giulioni M, Marucci G, Martinoni M, Volpi L, Riguzzi P, Marliani AF, et al. Seizure outcome in surgically treated drug-resistant mesial temporal lobe epilepsy based on the recent histopathological classifications. J Neurosurg. 2013;119(1):37–47.
36.
Pejović AT, Ristić AJ, Baščarević V, Brajković L, Berisavac I, Vojvodić N, et al. Surgical management of meningoencephalocele in temporal bone associated with pharmacoresistant epilepsy: report of 2 cases. Br J Neurosurg. 2019;33(2):207–9.
37.
Morley JF, Kolson DL. Frontal encephalocele in a middle-aged woman with first seizure: smells like a seizure to me. Neurology. 2008;70(2):157.
38.
Bui CJ, Tubbs RS, Shannon CN, Acakpo-Satchivi L, Wellons JC3rd, Blount JP, et al. Institutional experience with cranial vault encephaloceles. J Neurosurg. 2007;107(1 Suppl):22–5.
39.
Seeburg D, Ahn E, Huisman T. Secondary pediatric encephalocele after ventriculosubgaleal shunting for posthemorrhagic hydrocephalus. Neuropediatrics. 2014;45(4):252–5.
40.
Leelanukrom R, Wacharasint P, Kaewanuchit A. Perioperative management for surgical correction of frontoethmoidal encephalomeningocele in children: a review of 102 cases. Paediatr Anaesth. 2007;17(9):856–62.
41.
Krishnan P, Chattopadhyay A, Saha M. Periventricular nodular heterotopia, frontonasal encephalocele, corpus callosal dysgenesis and arachnoid cyst: a constellation of abnormalities in a child with epilepsy. J Pediatr Neurosci. 2014;9(3):273–5.
42.
Kennedy EM, Gruber DP, Billmire DA, Crone KR. Transpalatal approach for the extracranial surgical repair of transsphenoidal cephaloceles in children. J Neurosurg. 1997;87(5):677–81.
43.
Jenner ZB, Husein N, Riascos R, Esquenazi Y. Orbital and nasal meningoencephaloceles secondary to chronic hydrocephalus: a rare cause of bilateral proptosis. Neuroradiol J. 2018;31(4):420–5.
44.
Melbourne‐Chambers R, Singh Minott I, Mowatt L, Johnson P, Thame M. Aicardi syndrome associated with anterior cephalocele in a female infant. Dev Med Child Neurol. 2007;49(6):464–6.